# Nuclide record paper-baum-prrt-1048-patients-oncotarget-2018 (paper). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/key-papers/paper-baum-prrt-1048-patients-oncotarget-2018/>
  a schema:ScholarlyArticle ;
  nuclide:kind "paper" ;
  schema:identifier "paper-baum-prrt-1048-patients-oncotarget-2018" ;
  schema:name "Results and adverse events of personalised peptide receptor radionuclide therapy in 1048 patients with neuroendocrine neoplasms"@en ;
  schema:description "The largest single-centre report of a radioactive treatment for neuroendocrine tumours, from over a thousand patients treated across a decade at one German hospital, showing typical survival times and how often serious side effects such as blood cancers occurred."@en ;
  schema:url <https://nuclide.cc/key-papers/paper-baum-prrt-1048-patients-oncotarget-2018/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://pmc.ncbi.nlm.nih.gov/articles/PMC5908296/>, <https://pubmed.ncbi.nlm.nih.gov/29682217/> ;
  nuclide:tag "neuroendocrine tumours", "PRRT", "real-world evidence" ;
  schema:sameAs <https://doi.org/10.18632/oncotarget.24524> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Baum RP, Kulkarni HR, Singh A, Kaemmerer D, Mueller D, et al." ;
  nuclide:related <https://nuclide.cc/technologies/prrt/>, <https://nuclide.cc/drugs/lutathera/>, <https://nuclide.cc/indications/neuroendocrine/>, <https://nuclide.cc/technologies/radioligand-dosimetry/>, <https://nuclide.cc/people/richard-baum/>, <https://nuclide.cc/key-papers/paper-netter-1-nejm-2017/>, <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/lu-177/>, <https://nuclide.cc/isotopes/y-90/> .